Psoriatic Arthritis News

Patients with serious skin complications associated with rheumatic diseases may face a host of obstacles. Misdiagnosis is common. They are treated with non-curative therapies that can carry complications. Where rheumatology ends and dermatology begins is often a blurry line, so patients find themselves volleying between specialties. They veer in and out of remission.

Patients with moderate-to-severe psoriasis without hepatitis who were seropositive for hepatitis B core antibody only or hepatitis C infection, and who were being treated with biologic therapies, had minimal or no risk for viral reactivation, according to study results recently published in the Journal of the American Academy of Dermatology.

Despite being heralded as lower-cost alternatives to branded biologics, the approval of biosimilar therapies for chronic diseases is not likely to yield expected cost savings due to a number of state and payer policies, according to an opinion piece published in JAMA.

The FDA has accepted to review the supplemental new drug applications of Xeljanz at 5 mg twice daily, as well as Xeljanz XR extended release at 11 mg once daily, both for the treatment of patients with psoriatic arthritis, according to a company press release.

Psoriatic arthritis was linked with diabetes, Cushing disease, hypothyroidism and osteoporosis, according to a recent analysis of Israeli patients.

The Committee for Medicinal Products for Human Use has recommended approval of biosimilars by Sandoz for rituximab and etanercept for the same indications as the respective reference products.

Janus kinase inhibitors have grown into a promising drug class for the treatment of rheumatoid arthritis, as these have an oral route of administration and are effective in patients with inadequate response to methotrexate, patients who have failed biologics and have helped patients who are methotrexate-naïve.

Yes, I started this Editorial by quoting myself — I do not think it is plagiarism as I am citing the source and I believe this is my quote. If not, then I am sorry but for all rheumatologists reading this Editorial, I don’t think this concept is earth-shattering news.

Enthesitis and dactylitis were associated with a greater burden of disease in patients with psoriatic arthritis, according to data published from the Corrona registry.

Patients with inflammatory arthritis who underwent total hip arthroplasty experienced higher rates of complications compared with patients who had osteoarthritis, according to results.